Line Uhrenholt

机构：Aalborg University Hospital, Aalborg University · ORCID：0000-0002-4047-7175

发表论文 34 篇 · 总被引 434 次 · h-index 8

代表论文

Incidence and severeness of COVID-19 hospitalization in patients with inflammatory rheumatic disease: a nationwide cohort study from Denmark (2020 · Lara D. Veeken · 被引 127)
Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trial (2020 · BMJ · 被引 115)
Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial (2023 · Annals of the Rheumatic Diseases · 被引 55)
Risk of flare after tapering or withdrawal of biologic/targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis or axial spondyloarthritis: a systematic review and meta-analysis (2021 · Lara D. Veeken · 被引 37)
Using a novel smartphone application for capturing of patient-reported outcome measures among patients with inflammatory arthritis:A randomized, crossover, agreement study (2021 · Scandinavian Journal of Rheumatology · 被引 18)
Disease activity-guided tapering of biologics in patients with inflammatory arthritis: a pragmatic, randomized, open-label, equivalence trial (2023 · Scandinavian Journal of Rheumatology · 被引 12)